🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-09-20
Trial ID
NCT03169881
Treatments Being Tested
To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-03-09
Trial ID
NCT04862767
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The primary objective of this study is to evaluate the immunogenicity of na...
Status
Terminated
Location
Research Site
Start Date
2014-12-01
Trial ID
NCT02142192
Treatments Being Tested
This is a multi-center, randomized, double blind, placebo-controlled phase ...
Status
Completed
Location
Beijing Chao-Yang Hospital, Capital Medical University
Start Date
2021-02-24
Trial ID
NCT04805411
This is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, ...
Status
Terminated
Location
Medical Dermatology Specialists Site Number : 8400002
Start Date
2023-11-01
Trial ID
NCT06118099
Treatments Being Tested
To assess the effects of treatment with XOMA 052 on beta-cell function and ...
Status
Completed
Location
University Hospital Basel
Start Date
2009-09
Trial ID
NCT01788033
The primary objective of this study is to characterise the pharmacokinetics...
Status
Completed
Location
Research Site
Start Date
2013-12
Trial ID
NCT01978652
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of canv...
Status
Recruiting
Location
MBX Biosciences Investigational Site
Start Date
2026-08
Trial ID
NCT07699471
Treatments Being Tested
This study is evaluating the Pharmacokinetics of MNTX in healthy control su...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-03
Trial ID
NCT01367509
Treatments Being Tested